Rosai Dorfman disease (RDD) is a rare disorder that typically presents with bilateral cervical lymphadenopathy and follows a benign course.
Objective:
We present a case of late-onset atypical primary cutaneous RDD that is resistant to treatment modalities described in the literature.
Methods:
Case report.
Results:
An 84-year-old woman presented with a 7-year history of cutaneous lesions histologically consistent with RDD. She later failed initial treatments of acitretin and thalidomide.
Conclusion:
Physicians must be aware of unusual presentations of RDD. Also, further treatment options must be explored for patients resistant to classical management of RDD.
RosaiJDorfmanRF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol. 1969;87:63-70.
2.
AndrikoJAMorrisonAColegialCHet al. Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases. Mod Pathol. 2001;14:172-178.
3.
BrennTCalonjeEGranterSRet al. Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J Dermato-pathol. 2002;24:385-391.
4.
DaliaSSagatysESokolLet al. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21:322-327.
5.
FraterJLMaddoxJSObadiahJMet al. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg. 2006;10:281-290.
6.
KhanAASirajFRaiDet al. Rosai-Dorfman disease of the paranasal sinuses and orbit. Hematol Oncol Stem Cell Ther. 2011;4:94-96.
7.
MehraeinYWagnerMRembergerKet al. Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol. 2006;59:1320-1326.
8.
LevinePHJahanNMurariPet al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis. 1992;166:291-295.
9.
FoucarERosaiJDorfmanR. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19-73.
10.
LuCIKuoTTWongWRet al. Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol. 2004;51:931-939.
11.
PitamberHVGraysonW. Five cases of cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 2003;28:17-21.
12.
WangYGaoXTangWet al. Rosai-Dorfman disease isolated to the central nervous system: a report of six cases. Neuropathology. 2010;30:154-158.
13.
ChenHHZhouSHWangSQet al. Factors associated with recurrence and therapeutic strategies for sinonasal Rosai-Dorfman disease. Head Neck. 2012;34:1504-1513.
14.
FavaraBEFellerACPauliMet al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157-166.
15.
LopezPEstesML. Immunohistochemical characterization of the histiocytes in sinus histiocytosis with massive lymphadenopathy: analysis of an extranodal case. Hum Pathol. 1989;20:711-715.
16.
FarooqUChaconAHVincekVet al. Purely cutaneous Rosai-Dorfman disease with immunohistochemistry. Indian J Dermatol. 2013;58:447-450.
17.
FumertonRBallNZhouY. Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy. Cutis. 2011;87:296-299.
18.
MebazaaATrabelsiSDenguezliMet al. Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin. Int J Dermatol. 2007;46:1208-1210.
KongYYKongJCShiDRet al. Cutaneous Rosai-Dorfman disease: a clinical and histopathologic study of 25 cases in China. Am J Surg Pathol. 2007;31:341-350.
21.
ChangHSSonSJChoKHet al. Therapeutic challenge of dapsone in the treatment of purely cutaneous Rosai-Dorfman disease. Clin Exp Dermatol. 2011;36:420-422.
22.
FeningKBechtelMPetersSet al. Cutaneous Rosai-Dorfman disease persisting after surgical excision: report of a case treated with acitretin. J Clin Aesthet Dermatol. 2010;3:34-36.
23.
PottsCABozemanAPWalkerANet al. Cutaneous Rosai-Dorfman disease of the forearm: case report. J Hand Surg Am. 2008;33:1409-1413.
SalimAWilliamsonMBarkerFet al. Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism. Clin Exp Dermatol. 2002;27:277-279.
26.
Franco-ParedesCMartinK. Extranodal Rosai-Dorfman disease involving the meninges. South Med J. 2002;95:1101-1102.
27.
ShaverEGRebsamenSLYachnisATet al. Isolated extranodal intracranial sinus histiocytosis in a 5-year-old boy. Case report. J Neurosurg. 1993;79:769-773.
28.
UtikalJUgurelSKurzenHet al. Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses. Arch Dermatol. 2007;143:736-740.
29.
GoldbergSMahadeviaPLiptonMet al. Sinus histiocytosis with massive lymphadenopathy involving the orbit: reversal of compressive optic neuropathy after chemotherapy. J Neuroophthalmol. 1998;18:270-275.
30.
WuSYMaLTsaiYJ. Partial removal of orbital tumor in Rosai-Dorfman disease. Jpn J Ophthalmol. 2004;48:154-157.
31.
CooperSLChavisPSFortneyJAet al. A case of orbital Rosai-Dorfman disease responding to radiotherapy. J Pediatr Hematol Oncol. 2008;30:744-748.
32.
O’GallagherKDancyLSinhaAet al. Rosai-Dorfman disease and the heart. Intractable Rare Dis Res. 2016;5:1-5.
